Bifidobacterium bifidum – MB109 strain菌株

Cardiology blend | Cholesterol management
Bifidobacterium lactis – MB2409 (DSM 23733)
Bifidobacterium bifidum – MB109 (DSM 23731)
Bifidobacterium longum – 04 (DSM 23233)
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
1 billion CFU/strain

FUNCTIONALITY
Cardiovascular health ? Cholesterol lowering

Scientific support
Human clinical trial
Guardamagna O. et al. Bifidobacteria supplementation: effects on plasma lipid profile in dyslipidemic children. Nutrition (2014), doi: 10.1016/ j.nut. 2014.01.014.

In vitro and in vivo testing
Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.

Dietetics strain | Weight management
Characteristics
DAILY DOSAGE
1 billion CFU

FUNCTIONALITY
Restoration of a better dietary ω-6/ω-3 balance ? Conjugated linoleic acids (CLA) production ? Prospective use in the treatment of obesity ? Cholesterol management

Scientific support
Internal data available upon request

Gut-brain blend | Mood and sleep quality
Bifidobacterium longum – 04 (DSM 23233)
Lactobacillus fermentum – LF16 (DSM 26856)
Lactobacillus plantarum – LP01 (LMG P-21021)
Lactobacillus rhamnosus – LR06 (DSM 21981)
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
1 billion cfu/afu per strain

FUNCTIONALITY
Improvement of the quality of sleep ? Reduction of fatigue and anger ? Improvement of mood ? Inhibition of E. coli and Candida

Scientific support
Human clinical trial
Marotta A. et al., Effects of Probiotics on Cognitive Reactivity, Mood, and Sleep Quality, 2019 Frontiers in Psychiatry.

Supplier來源:BioVector NTCC Inc.
TEL電話:400-800-2947
Website網(wǎng)址: http://www.biovector.net